PortfoliosLab logoPortfoliosLab logo
XLI vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XLI vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Industrial Select Sector SPDR Fund (XLI) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XLI achieves a 13.90% return, which is significantly higher than ABBV's 1.30% return. Over the past 10 years, XLI has underperformed ABBV with an annualized return of 14.15%, while ABBV has yielded a comparatively higher 19.10% annualized return.


XLI

1D
0.59%
1M
0.96%
YTD
13.90%
6M
13.10%
1Y
25.17%
3Y*
20.87%
5Y*
12.93%
10Y*
14.15%

ABBV

1D
1.32%
1M
8.05%
YTD
1.30%
6M
3.65%
1Y
23.06%
3Y*
22.39%
5Y*
18.94%
10Y*
19.10%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XLI vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XLI
Industrial Select Sector SPDR Fund
13.90%19.35%17.31%18.13%-5.57%21.08%10.91%29.08%-13.25%23.98%
ABBV
AbbVie Inc.
1.30%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between XLI and ABBV is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.32

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.36

Over the past year, the correlation between XLI and ABBV has dropped to 0.14 - well below their long-term average of 0.36, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XLI vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XLI
XLI Risk / Return Rank: 4848
Overall Rank
XLI Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
XLI Sortino Ratio Rank: 5050
Sortino Ratio Rank
XLI Omega Ratio Rank: 4646
Omega Ratio Rank
XLI Calmar Ratio Rank: 4545
Calmar Ratio Rank
XLI Martin Ratio Rank: 5252
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6868
Overall Rank
ABBV Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6666
Sortino Ratio Rank
ABBV Omega Ratio Rank: 6565
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6868
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XLI vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Industrial Select Sector SPDR Fund (XLI) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XLIABBVDifference
Sharpe ratioReturn per unit of total volatility

+0.58

Sortino ratioReturn per unit of downside risk

+0.76

Omega ratioGain probability vs. loss probability

1.26

1.18

+0.08

Calmar ratioReturn relative to maximum drawdown

1.98

1.29

+0.70

Martin ratioReturn relative to average drawdown

7.82

2.88

+4.94

XLI vs. ABBV - Sharpe Ratio Comparison

The current XLI Sharpe Ratio is 1.50, which is higher than the ABBV Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of XLI and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XLI vs. ABBV - Drawdown Comparison

The maximum XLI drawdown since its inception was -62.26%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for XLI and ABBV.


Loading charts...

Drawdown Indicators


XLIABBVDifference

Max Drawdown

Largest peak-to-trough decline

-62.26%

-45.09%

-17.17%

Max Drawdown (1Y)

Largest decline over 1 year

-12.21%

-17.32%

+5.11%

Max Drawdown (3Y)

Largest decline over 3 years

-18.49%

-20.74%

+2.25%

Max Drawdown (5Y)

Largest decline over 5 years

-21.64%

-21.92%

+0.28%

Max Drawdown (10Y)

Largest decline over 10 years

-42.33%

-45.09%

+2.76%

Current Drawdown

Current decline from peak

-1.24%

-4.60%

+3.36%

Average Drawdown

Average peak-to-trough decline

-9.20%

-10.71%

+1.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.09%

7.75%

-4.66%

Volatility

XLI vs. ABBV - Volatility Comparison

Industrial Select Sector SPDR Fund (XLI) and AbbVie Inc. (ABBV) have volatilities of 6.22% and 6.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XLIABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.22%

6.10%

+0.12%

Volatility (6M)

Calculated over the trailing 6-month period

13.59%

17.85%

-4.26%

Volatility (1Y)

Calculated over the trailing 1-year period

16.17%

24.31%

-8.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.55%

22.89%

-5.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.04%

25.73%

-5.69%

Dividends

XLI vs. ABBV - Dividend Comparison

XLI's dividend yield for the trailing twelve months is around 1.16%, less than ABBV's 2.96% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.96%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
XLI
Industrial Select Sector SPDR Fund
1.16%1.29%1.44%1.63%1.63%1.25%1.55%1.94%2.15%1.77%2.07%2.15%

Frequently Asked Questions


XLI and ABBV have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XLI has higher volatility (6.22%) compared to ABBV (6.10%). In terms of maximum drawdown, XLI dropped -62.26% vs ABBV's -45.09%.

XLI currently has the higher Sharpe Ratio (1.50 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XLI and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer